Report Detail

The Europe apheresis equipment market is expected to reach US$ 1,034.54 Mn in 2027 from US 606.82 in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.
The growth of the apheresis equipment market is primarily attributed to the increasing prevalence of cardiovascular diseases and the increasing elderly population. However, risk associated with apheresis are likely to have a negative impact on market growth. On the other hand, growing high quality services for hematology diseases is likely to have a positive impact on the growth of the Europe apheresis equipment market in the coming years.
Apheresis is a process in which blood is temporarily removed from the donor’s body and separated into various components such as plasma, platelets, red blood cells as well as white blood cells. It is done by centrifugation or membrane separation process. Few diseases are caused by certain type of genes. Anemia, hemophilia, von Willebrand disease (VWD), blood cancers such as myeloma, leukemia-lymphoma are some of the common blood diseases. The rising number of these diseases demands the need for a blood transfusion which is expected to increase the requirement of apheresis equipment, thereby bolstering the growth of the market.
The heart disease is mostly pone to the geriatric population due to weak immunity and significant other health problems. Aging is a process strongly influenced by genetic variables as well as environmental factors. Geriatric population generally have to thick heart and blood vessels that lead to heart disorders. Thus, the people with the age of 75 years and above high blood pressure is the common risk factor for the hematological diseases, including blood-associated cancer. Management of hematologic disorders in geriatric patients must often be weighed in a setting of decreased physiological reserves and concurrent illnesses.
In 2017, Europe has the high percentage of population aging more than 60 or above. The fast and rapid ageing is occurring in other parts of the world as well, so that by 2050 all regions of the world except Africa will have nearly a quarter or more of their populations at ages 60 and above. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050 and will rise above US$ 3.1 billion in 2100. The elderly population is quicker to have atypical presentations, comorbid conditions, and adverse outcomes. The primary reason for the disease is related to the structural and functional changes in the cardiovascular system associated with aging.
In 2018, the disposable apheresis kits segment held the largest market share of the apheresis equipment market, by product. The disposable apheresis kits segment is also expected to dominate its market share in 2027 as the disposable apheresis kits are used on a large scale while conducting the procedure. Since these kits are intended for single-use and the number of apheresis procedures has been increasing, the demand for the disposable apheresis kits segment is anticipated to grow at a considerable rate.
In 2018, the membrane separation held a largest market share of the apheresis equipment market, by technology. This segment is also expected to dominate the market in 2027. Moreover, the segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.
In 2018, the plasmapheresis segment held a largest market share of the apheresis equipment market, by procedure. This segment is also expected to dominate the market in 2027 owing to the increasing applications of the procedure. However, the LDL-Apheresis segment is expected to grow at faster rate due to the technique is used for the treatment of other rare diseases such as familial hypercholesterolemia.
In 2018, the hospitals & clinics segment held a largest market share of the apheresis equipment market, by end user. This segment is also expected to dominate the market in 2027. Moreover, the similar segment is expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for apheresis equipment included in the report are, European Medicines Agency, World Health Organization (WHO), European Renal Association, European Kidney Health Alliance (EKHA), National Health Service(NHS), Organization for Economic Co-operation and Development (OECD) and others.


TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance

    2. Europe Apheresis Equipment Market – Key Takeaways

      3. Europe Apheresis Equipment Market – Market Landscape

      • 3.1 Overview
      • 3.2 Market Segmentation
        • 3.2.1 Europe Apheresis Equipment Market – By Product
        • 3.2.2 Europe Apheresis Equipment Market – By Technology
        • 3.2.3 Europe Apheresis Equipment Market – By Procedure
        • 3.2.4 Europe Apheresis Equipment Market – By Therapeutic Area
        • 3.2.5 Europe Apheresis Equipment Market – By End User
        • 3.2.6 Europe Apheresis Equipment Market – By Country
      • 3.3 PEST Analysis

      4. Europe Apheresis Equipment Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Increasing Prevalence of Cardiovascular Diseases
        • 4.1.2 Increasing Elderly Population
      • 4.2 Key Market Restraints
        • 4.2.1 Risk Associated with Procedure
      • 4.3 Key Market Opportunities
        • 4.3.1 Growing High Quality Services For Haematology Diseases
      • 4.4 Future Trends
        • 4.4.1 Advancement in Therapeutic Apheresis
      • 4.5 Impact Analysis

      5. Apheresis Equipment Market – Europe Analysis

      • 5.1 Europe Apheresis Equipment Market Revenue Forecasts And Analysis
      • 5.2 Market Positioning

      6. Europe Apheresis Equipment Market Analysis – By Product

      • 6.1 Overview
      • 6.2 Europe Apheresis Equipment Market By Product, 2018 & 2027 (%)
      • 6.3 Europe Apheresis Equipment Market Revenue And Forecasts to 2027, By Product (US$ Mn)
      • 6.4 Disposable Apheresis Kits Market
        • 6.4.1 Overview
        • 6.4.2 Global Disposable Apheresis Kits Market Revenue and Forecasts to 2027 (US$ Mn)
      • 6.5 Apheresis Machine Market
        • 6.5.1 Overview
        • 6.5.2 Europe Apheresis Machine Market Revenue and Forecasts to 2027 (US$ Mn)

      7. Europe Apheresis Equipment Market Analysis – By Technology

      • 7.1 Overview
      • 7.2 Europe Apheresis Equipment Market, By Technology, 2018 & 2027 (%)
      • 7.3 Europe Apheresis Equipment Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
      • 7.4 Centrifugation Market
        • 7.4.1 Overview
        • 7.4.2 Europe Centrifugation Market Revenue and Forecasts to 2027 (US$ Mn)
      • 7.5 Membrane Separation Market
        • 7.5.1 Overview
        • 7.5.2 Global Membrane Separation Market Revenue and Forecasts to 2027 (US$ Mn)

      8. Europe Apheresis Equipment Market Analysis – By Procedure

      • 8.1 Overview
      • 8.2 Europe Apheresis Equipment Market, By Procedure, 2018 & 2027 (%)
      • 8.3 Europe Apheresis Equipment Market Revenue And Forecasts to 2027, By Procedure (US$ Mn)
      • 8.4 Plasmapheresis Market
        • 8.4.1 Overview
        • 8.4.2 Europe Plasmapheresis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.5 Photopheresis Market
        • 8.5.1 Overview
        • 8.5.2 Europe Photopheresis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.6 Erythrocytapheresis Market
        • 8.6.1 Overview
        • 8.6.2 Europe Erythrocytapheresis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.7 Leukapheresis Market
        • 8.7.1 Overview
        • 8.7.2 Europe Leukapheresis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.8 Plateletpheresis Market
        • 8.8.1 Overview
        • 8.8.2 Europe Plateletpheresis Market Revenue and Forecasts to 2027 (US$ Mn)
      • 8.9 LDL-Apheresis Market
        • 8.9.1 Overview
        • 8.9.2 Europe LDL-Apheresis Market Revenue and Forecasts to 2027 (US$ Mn)

      9. Europe Apheresis Equipment Market Analysis – By Therapeutic Area

      • 9.1 Overview
      • 9.2 Europe Apheresis Equipment Market, By Therapeutic Area, 2018 & 2027 (%)
      • 9.3 Europe Apheresis Equipment Market Revenue And Forecasts to 2027, By Therapeutic Area (US$ Mn)
      • 9.4 Haematology Market
        • 9.4.1 Overview
        • 9.4.2 Europe Haematology Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5 Renal Diseases Market
        • 9.5.1 Overview
        • 9.5.2 Europe Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6 Neurology Market
        • 9.6.1 Overview
        • 9.6.2 Europe Neurology Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.7 Other Applications Market
        • 9.7.1 Overview
        • 9.7.2 Europe Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

      10. Europe Apheresis Equipment Market Analysis – By End User

      • 10.1 Overview
      • 10.2 Europe Apheresis Equipment Market, By End User, 2018 & 2027 (%)
      • 10.3 Europe Apheresis Equipment Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 10.4 Hospitals & Clinics
        • 10.4.1 Overview
        • 10.4.2 Europe Hospitals & Clinics Market Revenue and Forecast to 2027 (US$ Mn)
      • 10.5 Blood Banks/ Blood Donation Centers
        • 10.5.1 Overview
        • 10.5.2 Europe Blood Banks/ Blood Donation Centers Market Revenue and Forecast to 2027 (US$ Mn)
      • 10.6 Ambulatory Surgical Centers
        • 10.6.1 Overview
        • 10.6.2 Europe Ambulatory Surgical Centers Market Revenue and Forecast to 2027 (US$ Mn)

      11. Europe Apheresis Equipment Market Revenue and Forecasts To 2027

      • 11.1 Overview
        • 11.1.1 Europe Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
        • 11.1.2 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
        • 11.1.3 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
        • 11.1.4 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
        • 11.1.5 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
        • 11.1.6 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 11.1.7 Europe Apheresis Equipment Market Revenue and Forecasts to 2027, By Country (%)
        • 11.1.8 Germany Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.8.1 Germany Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.8.2 Germany Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
          • 11.1.8.3 Germany Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 11.1.8.4 Germany Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
          • 11.1.8.5 Germany Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
          • 11.1.8.6 Germany Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 11.1.9 UK Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.9.1 UK Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.9.2 UK Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
          • 11.1.9.3 UK Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 11.1.9.4 UK Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
          • 11.1.9.5 UK Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
          • 11.1.9.6 UK Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 11.1.10 France Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.10.1 France Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.10.2 France Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
          • 11.1.10.3 France Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 11.1.10.4 France Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
          • 11.1.10.5 France Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
          • 11.1.10.6 France Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 11.1.11 Spain Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.11.1 Spain Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.11.2 Spain Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
          • 11.1.11.3 Spain Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 11.1.11.4 Spain Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
          • 11.1.11.5 Spain Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
          • 11.1.11.6 Spain Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
        • 11.1.12 Italy Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.12.1 Italy Apheresis Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
          • 11.1.12.2 Italy Apheresis Equipment Market Revenue and Forecasts to 2027, By Product (US$ Mn)
          • 11.1.12.3 Italy Apheresis Equipment Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
          • 11.1.12.4 Italy Apheresis Equipment Market Revenue and Forecasts to 2027, By Procedure (US$ Mn)
          • 11.1.12.5 Italy Apheresis Equipment Market Revenue and Forecasts to 2027, By Therapeutic Area (US$ Mn)
          • 11.1.12.6 Italy Apheresis Equipment Market Revenue and Forecasts to 2027, By End User (US$ Mn)
      • 11.2 Source: The Insight Partners

      12. Apheresis Equipment Market – Industry Landscape

      • 12.1 Overview

      13. Apheresis Equipment Market–Key Company Profiles

      • 13.1 Medica S.p.A.
        • 13.1.1 Key Facts
        • 13.1.2 Business Description
        • 13.1.3 Financial Overview
        • 13.1.4 Product Portfolio
        • 13.1.5 SWOT Analysis
        • 13.1.6 Key Developments
      • 13.2 Fresenius Medical Care AG & Co. KGaA
        • 13.2.1 Key Facts
        • 13.2.2 Business Description
        • 13.2.3 Financial Overview
        • 13.2.4 Product Portfolio
        • 13.2.5 SWOT Analysis
        • 13.2.6 Key Developments
      • 13.3 Asahi Kasei Corporation
        • 13.3.1 Key Facts
        • 13.3.2 Business Description
        • 13.3.3 Financial Overview
        • 13.3.4 Product Portfolio
        • 13.3.5 SWOT Analysis
        • 13.3.6 Key Developments
      • 13.4 Terumo Corporation
        • 13.4.1 Key Facts
        • 13.4.2 Business Description
        • 13.4.3 Financial Overview
        • 13.4.4 Product Portfolio
        • 13.4.5 SWOT Analysis
        • 13.4.6 Key Developments
      • 13.5 B. Braun Melsungen AG
        • 13.5.1 Key Facts
        • 13.5.2 Business Description
        • 13.5.3 Financial Overview
        • 13.5.4 Product Portfolio
        • 13.5.5 SWOT Analysis
        • 13.5.6 Key Developments
      • 13.6 Haemonetics Corporation
        • 13.6.1 Key Facts
        • 13.6.2 Business Description
        • 13.6.3 Financial Overview
        • 13.6.4 Product Portfolio
        • 13.6.5 SWOT Analysis
        • 13.6.6 Key Developments
      • 13.7 Hemacare Corporation
        • 13.7.1 Key Facts
        • 13.7.2 Business Description
        • 13.7.3 Financial Overview
        • 13.7.4 Product Portfolio
        • 13.7.5 SWOT Analysis
        • 13.7.6 Key Developments
      • 13.8 Kaneka Medix Corp
        • 13.8.1 Key Facts
        • 13.8.2 Business Description
        • 13.8.3 Financial Overview
        • 13.8.4 Product Portfolio
        • 13.8.5 SWOT Analysis
        • 13.8.6 Key Developments
      • 13.9 Kawasumi laboratories. Inc.
        • 13.9.1 Key Facts
        • 13.9.2 Business Description
        • 13.9.3 Financial Overview
        • 13.9.4 Product Portfolio
        • 13.9.5 SWOT Analysis
        • 13.9.6 Key Developments
      • 13.10 medicap clinic GmbH
        • 13.10.1 Key Facts
        • 13.10.2 Business Description
        • 13.10.3 Financial Overview
        • 13.10.4 Product Portfolio
        • 13.10.5 SWOT Analysis
        • 13.10.6 Key Developments

      14. Appendix

      • 14.1 About The Insight Partners
      • 14.2 Glossary Of Terms
      • 14.3 Methodology
        • 14.3.1 Coverage
        • 14.3.2 Secondary Research
        • 14.3.3 Primary Research

      Summary:
      Get latest Market Research Reports on Europe Apheresis Equipment . Industry analysis & Market Report on Europe Apheresis Equipment is a syndicated market report, published as Europe Apheresis Equipment Market to 2027 - Regional Analysis and Forecasts By Product (Apheresis Machine, Disposable Apheresis Kits); Technology (Membrane Separation, Centrifugation); Procedure (Erythrocytapheresis, LDL Apheresis, Leukapheresis, Photopheresis, Plasmapheresis, Plateletpheresis); Therapeutic Area (Renal Diseases, Hematology, Neurology, Other Applications); End User (Hospitals & Clinics, Ambulatory Surgical Centers, Blood Donation Centers), and Country. It is complete Research Study and Industry Analysis of Europe Apheresis Equipment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,394.00
      3,192.00
      3,990.00
      2,799.00
      3,732.00
      4,665.00
      461,280.00
      615,040.00
      768,800.00
      250,380.00
      333,840.00
      417,300.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report